| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Anavex Life Sciences Corp (NASDAQ: AVXL)
AVXL Technical Analysis
5
| As on 9th Jun 2023 AVXL STOCK Price closed @ 9.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 11.26 & Strong Sell for SHORT-TERM with Stoploss of 13.34 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AVXLSTOCK Price
| Open | 9.28 | Change | Price | % |
| High | 10.17 | 1 Day | -0.09 | -0.97 |
| Low | 8.91 | 1 Week | -0.09 | -0.97 |
| Close | 9.15 | 1 Month | 0.96 | 11.72 |
| Volume | 3978066 | 1 Year | -9.41 | -50.70 |
| 52 Week High 19.50 | 52 Week Low 7.31 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AVXL Daily Charts |
AVXL Intraday Charts |
Whats New @ Bazaartrend |
AVXL Free Analysis |
|
|
AVXL Important Levels Intraday
| RESISTANCE | 11.58 |
| RESISTANCE | 10.80 |
| RESISTANCE | 10.32 |
| RESISTANCE | 9.84 |
| SUPPORT | 8.46 |
| SUPPORT | 7.98 |
| SUPPORT | 7.50 |
| SUPPORT | 6.72 |
AVXL Forecast April 2024
| 4th UP Forecast | 21.42 |
| 3rd UP Forecast | 17.49 |
| 2nd UP Forecast | 15.05 |
| 1st UP Forecast | 12.62 |
| 1st DOWN Forecast | 5.68 |
| 2nd DOWN Forecast | 3.25 |
| 3rd DOWN Forecast | 0.81 |
| 4th DOWN Forecast | -3.12 |
AVXL Weekly Forecast
| 4th UP Forecast | 16.22 |
| 3rd UP Forecast | 13.95 |
| 2nd UP Forecast | 12.55 |
| 1st UP Forecast | 11.15 |
| 1st DOWN Forecast | 7.15 |
| 2nd DOWN Forecast | 5.75 |
| 3rd DOWN Forecast | 4.35 |
| 4th DOWN Forecast | 2.08 |
AVXL Forecast2024
| 4th UP Forecast | 33.62 |
| 3rd UP Forecast | 25.77 |
| 2nd UP Forecast | 20.92 |
| 1st UP Forecast | 16.07 |
| 1st DOWN Forecast | 2.23 |
| 2nd DOWN Forecast | -2.62 |
| 3rd DOWN Forecast | -7.47 |
| 4th DOWN Forecast | -15.32 |
Anavex Life Sciences Corp ( NASDAQ USA Symbol : AVXL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AVXL Business Profile
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials to treat Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company is based in New York, New York. Address: 51 West 52nd Street, New York, NY, United States, 10019
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service